Cdxs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cdxs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cdxs Today - Breaking & Trending Today

Codexis (NASDAQ:CDXS) Stock Rating Reaffirmed by Benchmark

Codexis (NASDAQ:CDXS – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at Benchmark in a research report issued to clients and investors on Friday, Benzinga reports. They presently have a $9.00 target price on the biotechnology company’s stock. Benchmark’s target price suggests a potential upside of 129.59% from the stock’s current […] ....

Kent Lake Capital , Opaleye Management Inc , Codexis Inc , Capital Partners , Get Free Report , Lake Capital , Performance Enzymes , Codexis Daily , Nasdaq Cdxs , Reiterated Rating , Benchmark Co ,

Codexis, Inc. (NASDAQ:CDXS) Given Average Recommendation of "Moderate Buy" by Brokerages

Codexis, Inc. (NASDAQ:CDXS – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six analysts that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target among analysts that have […] ....

Codexis Inc , York Mellon Corp , Royal Bank , Envestnet Asset Management Inc , Get Free Report , New York Mellon Corp , Asset Management , Get Free , Performance Enzymes , Codexis Daily , Nasdaq Cdxs ,

Codexis, Inc. (NASDAQ:CDXS) Receives $6.80 Consensus Target Price from Analysts

Codexis, Inc. (NASDAQ:CDXS – Get Free Report) has earned an average rating of “Moderate Buy” from the six research firms that are covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price target among […] ....

Codexis Inc , Codexis Company Profile , Ameriprise Financial Inc , Opaleye Management Inc , Millennium Management , Get Free Report , Get Free , Performance Enzymes , Codexis Daily , Nasdaq Cdxs ,

Codexis, Inc. (NASDAQ:CDXS) Receives $6.80 Consensus Target Price from Analysts

Codexis, Inc. (NASDAQ:CDXS – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month target price among […] ....

Codexis Inc , Vanguard Group Inc , Opaleye Management Inc , Nantahala Capital Management , Blackrock Inc , Get Free Report , Capital Management , Opaleye Management , Get Free , Performance Enzymes , Codexis Daily , Nasdaq Cdxs ,

Brokerages Set Codexis, Inc. (NASDAQ:CDXS) PT at $7.17

Shares of Codexis, Inc. (NASDAQ:CDXS – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year […] ....

New York , United States , Byronl Dorgan , Piper Sandler , Jacob Asset Management Of New York , Codexis Inc , Paradigm Capital Management Inc , Securities Exchange Commission , Sg Americas Securities , Get Free Report , Marketbeat Ratings , Director Byron , Exchange Commission , Asset Management , Capital Management , Strs Ohio , Get Free , Performance Enzymes , Codexis Daily , Nasdaq Cdxs ,